Federico Rotolo

Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer

Siddhartha Devarakonda, Federico Rotolo, Ming‐Sound Tsao et al. · Journal of Clinical Oncology · 2018 · 293 citations · Full text

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial

M. Bagot, Pierluigi Porcu, Anne Marie‐Cardine et al. · The Lancet Oncology · 2019 · 154 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +8

Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L)1 inhibitors.

Roger B. Cohen, Jessica R. Bauman, Sébastien Salas et al. · Journal of Clinical Oncology · 2020 · 40 citations

Immunology, Immunoediting, Pathology +23

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort

M. Kandel, Clara Allayous, Stéphane Dalle et al. · European Journal of Cancer · 2018 · 38 citations

Melbase Cohort, Medicine, Melanoma +7

Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients

Annabelle Stoclin, Federico Rotolo, Yassine Hicheri et al. · Supportive Care in Cancer · 2019 · 38 citations · Full text

Acute Care, Patient Safety, Bloodstream Infections +7